Filing Details
- Accession Number:
- 0001209191-15-076368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-21 18:14:53
- Reporting Period:
- 2015-10-19
- Filing Date:
- 2015-10-21
- Accepted Time:
- 2015-10-21 18:14:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1182657 | Md H Frank Valone | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-19 | 10,000 | $2.35 | 94,044 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-19 | 10,000 | $23.00 | 84,044 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-10-19 | 10,000 | $0.00 | 10,000 | $2.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | 2018-12-03 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- Fully vested.